Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|24|2401-2414

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.24, 2008-08, pp. : 2401-2414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibodies for prophylaxis and therapy of infectious diseases

By Meulen Jan ter  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 4, 2007-11 ,pp. : 525-540

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4498-4507

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a PBPK Model for Monoclonal Antibodies and Simulation of Human and Mice PBPK of a Radiolabelled Monoclonal Antibody

By  

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 988-1007

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies

By  

Current Drug Metabolism, Vol. 10, Iss. 7, 2009-09 ,pp. : 661-691

Bentham Science Publishers

Access to resources Recommend Favorite

Making the Most of Monoclonal Antibodies: Genmab Gunning for Blockbuster

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 11, 2006-01 ,pp. : 10-12

Adis International

Access to resources Recommend Favorite